Treatment groups by regimen. SOF, sofosbuvir; LDV, ledipasvir; SIM,... | Download Scientific Diagram
Six weeks of sofosbuvir/ledipasvir (SOF/LDV) are sufficient to treat acute hepatitis C virus genotype 1 monoinfection: The HepNet Acute HCV IV Study
Incremental cost and effectiveness of SOF/VEL relative to SOF/LDV in... | Download Scientific Diagram
Informe d'avaluació de resultats del tractament antiviral de l'hepatitis C a l'any 2018
Treatment outcomes for SOF/LDV without RBV for HCV genotype 1 (1a, 1b,... | Download Scientific Diagram
Tratamiento de la hepatitis C en el pre- y postrasplante hepático | Gastroenterología y Hepatología
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/ LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV) | Scientific Reports
Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis C | Anales de Pediatría
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study | PLOS ONE
Incremental cost and effectiveness of SOF/LDV and SOF/VEL relative to... | Download Scientific Diagram
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/ LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV) | Scientific Reports
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Antiviral activity of LDV and SOF as monotherapy (A) and combination... | Download Scientific Diagram
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C - ScienceDirect
Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis - ScienceDirect
Respuestas para un nuevo abordaje de la hepatitis C
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China
EVALUACION DE LA EFICACIA Y SEGURIDAD DE LOS TRATAMIENTOS CON LOS NUEVOS ANTIVIRALES DIRECTOS DEL VHC EN PACIENTES COINFECTADOS